Cas:1680184-59-1 Afatinib iMpurity manufacturer & supplier

Chemical Name:Afatinib iMpurity

CAS.NO:1680184-59-1

Synonyms:(2Z)-N-{4-[(3-Chloro-4-fluorophenyl)amino]-7-[(3S)-tetrahydro-3-furanyloxy]-6-quinazolinyl}-4-(dimethylamino)-2-butenamide;2-Butenamide, N-[4-[(3-chloro-4-fluorophenyl)amino]-7-[[(3S)-tetrahydro-3-furanyl]oxy]-6-quinazolinyl]-4-(dimethylamino)-, (2Z)-

Molecular Formula:C₂₄H₂₅ClFN₅O₃

Molecular Weight:485.938

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:676.9±55.0 °C at 760 mmHg

Density:1.4±0.1 g/cm3

Index of Refraction:1.668

PSA:

Exact Mass:485.162994

LogP:3.59

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like (2Z)-N-{4-[(3-Chloro-4-fluorophenyl)amino]-7-[(3S)-tetrahydro-3-furanyloxy]-6-quinazolinyl}-4-(dimethylamino)-2-butenamide chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-Butenamide, N-[4-[(3-chloro-4-fluorophenyl)amino]-7-[[(3S)-tetrahydro-3-furanyl]oxy]-6-quinazolinyl]-4-(dimethylamino)-, (2Z)- physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-Butenamide, N-[4-[(3-chloro-4-fluorophenyl)amino]-7-[[(3S)-tetrahydro-3-furanyl]oxy]-6-quinazolinyl]-4-(dimethylamino)-, (2Z)- Use and application,(2Z)-N-{4-[(3-Chloro-4-fluorophenyl)amino]-7-[(3S)-tetrahydro-3-furanyloxy]-6-quinazolinyl}-4-(dimethylamino)-2-butenamide technical grade,usp/ep/jp grade.

Related News: With the speeding up of review and approval, the number of approved innovative drugs in China is about to usher in a year of blowout. Afatinib iMpurity manufacturer This includes chemical APIs. Afatinib iMpurity supplier It is foreseeable that in the future, the capacity and output of bulk APIs in China will decrease, the supply-demand relationship will be balanced, and prices and profits will gradually return to a more reasonable range. The era of low prices in the past will be gone forever. Individual APIs Varieties may even lose their price competitive advantage and move abroad. Afatinib iMpurity vendor Standard respiratory support therapies are used to treat the symptoms and wait for the virus to be cleared by itself. Afatinib iMpurity factory It is foreseeable that in the future, the capacity and output of bulk APIs in China will decrease, the supply-demand relationship will be balanced, and prices and profits will gradually return to a more reasonable range. The era of low prices in the past will be gone forever. Individual APIs Varieties may even lose their price competitive advantage and move abroad.